arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Tonix Pharmaceuticals Holding Corp.

TNXP Health Care Biotechnology: Pharmaceutical Preparations
$5.17
▼ -4.8% Today
as of Oct 23, 16:52 ET
Last 30 days -55.92% Sep 14 → Oct 23
$4.60 $6.52 $8.45 $10.37 $12.29 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$5.09
High
$5.20
Low
$5.02
Volume
$750,628
Avg Vol
$544,911
Mkt Cap
$158M
P/E (TTM)
—
Beta
—
52w High
$20.58
52w Low
$5.02
Div Yield
—
Shares Out
$17M

Recent Press Releases & News last 60 days · 7 items

Oct 19 · 11:00 PR GlobeNewswire
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
Oct 15 · 11:00 PR GlobeNewswire
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026
Sep 22 · 11:00 PR GlobeNewswire
Tonix Pharmaceuticals Announces Second Major Managed Medicare Payer Agreement for TONMYA®
▸ Show all 7 press releases & news Free account →

TNXP earnings at a glance

The options market is pricing a move of about ±26.4% after the report, a range of roughly $3.81 to $6.53 from today's $5.17. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±1.0% on average; after the most recent report on May 11, 2026 it moved +0.1%. That means options currently expect more movement than TNXP has typically delivered. TNXP beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 169%. The share price of $5.17 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$5.02
$21
1% of range
Avg surprise (last 4)
-8.9%
Avg reaction (last 2)
+1.0%
100% positive
Latest IV / EM
169%
EM ±26.4% · $10 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1920.85$-1441.23$-961.62$-482.00$-2.38 Actual $-3.21Actual $-49.23Actual $-38.63Actual $-535.72Actual $-1920.85Actual $-22.68Actual $-2.84Est $-3.23Actual $-3.86Est $-3.10Actual $-3.59Est $-3.59Actual $-2.93Est $-2.38Actual $-2.44 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-41M$-27M$-13M$527,900$14M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-2.44 — — — — financials
Mon May 11, 2026Mar/2026 $-2.93 $-2.38 -23.1% -3.2% +0.1% earnings
Mon Nov 10, 2025Sep/2025 $-3.59 $-3.59 0.0% — — earnings
Mon Aug 11, 2025Jun/2025 $-3.86 $-3.10 -24.5% — — earnings
Mon May 12, 2025Mar/2025 $-2.84 $-3.23 +12.1% — +1.9% earnings
Mon Sep 30, 2024Sep 2024 $-22.68 — — — — financials
Sun Jun 30, 2024Jun 2024 $-1920.85 — — — — financials
Sun Mar 31, 2024Mar 2024 $-535.72 — — — — financials
Sat Sep 30, 2023Sep 2023 $-38.63 — — — — financials
Fri Jun 30, 2023Jun 2023 $-49.23 — — — — financials
Fri Mar 31, 2023Mar 2023 $-3.21 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$14M$7M—$3M$2M$2M—$3M
Cost of revenue$703,000$2M—$1M$3M$943,000—$2M
Gross profit————————
Operating income$-43M$-42M—$-33M$-28M$-16M—$-16M
Net income$-41M$-40M—$-32M$-28M$-17M—$-14M
EPS (diluted)$-2.44$-2.93—$-3.59$-3.86$-2.84—$-22.68

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$176M$185M$208M$190M$125M$132M$99M$28M
Inventory———————$8M
Total current assets$203M$207M$229M$208M$144M$150M$119M$51M
Total assets$254M$258M$277M$252M$187M$193M$163M$95M
Long-term debt——————$5M$5M
Total liabilities$32M$31M$32M$21M$19M$12M$23M$21M
Total equity$222M$227M$245M$231M$168M$180M$140M$74M

Implied volatility — last 90 days

49%157%265%373%481% Jun 08 — IV 144% · EM ±19.0%Jun 09 — IV 167% · EM ±20.9%Jun 10 — IV 259% · EM ±30.6%Jun 11 — IV 166% · EM ±18.4%Jun 12 — IV 149% · EM ±15.2%Jun 15 — IV 162% · EM ±11.7%Jun 16 — IV 175% · EM ±10.3%Jun 17 — IV 152% · EM ±6.4%Jun 19 — IV 106% · EM ±23.3%Jun 22 — IV 198% · EM ±41.4%Jun 23 — IV 93% · EM ±19.1%Jun 24 — IV 91% · EM ±18.2%Jun 25 — IV 103% · EM ±20.2%Jun 26 — IV 122% · EM ±23.4%Jun 29 — IV 101% · EM ±17.9%Jun 30 — IV 102% · EM ±17.6%Jul 01 — IV 110% · EM ±18.4%Jul 02 — IV 98% · EM ±15.8%Jul 03 — IV 101% · EM ±15.8%Jul 06 — IV 132% · EM ±18.3%Jul 07 — IV 107% · EM ±14.1%Jul 08 — IV 78% · EM ±9.8%Jul 09 — IV 95% · EM ±11.2%Jul 10 — IV 130% · EM ±14.4%Jul 13 — IV 287% · EM ±23.9%Jul 14 — IV 331% · EM ±24.0%Jul 15 — IV 311% · EM ±18.3%Jul 16 — IV 364% · EM ±15.2%Jul 20 — IV 107% · EM ±25.2%Jul 21 — IV 100% · EM ±23.4%Jul 22 — IV 131% · EM ±30.0%Jul 23 — IV 180% · EM ±40.4%Jul 24 — IV 138% · EM ±30.6%Jul 27 — IV 125% · EM ±26.0%Jul 28 — IV 148% · EM ±30.2%Jul 29 — IV 117% · EM ±23.5%Jul 30 — IV 116% · EM ±22.6%Jul 31 — IV 106% · EM ±20.2%Aug 03 — IV 122% · EM ±21.6%Aug 04 — IV 130% · EM ±22.4%Aug 05 — IV 94% · EM ±15.8%Aug 06 — IV 180% · EM ±29.1%Aug 07 — IV 98% · EM ±15.4%Aug 10 — IV 107% · EM ±14.8%Aug 11 — IV 83% · EM ±10.9%Aug 12 — IV 70% · EM ±8.7%Aug 13 — IV 91% · EM ±10.8%Aug 14 — IV 94% · EM ±10.4%Aug 17 — IV 111% · EM ±9.3%Aug 18 — IV 126% · EM ±9.1%Aug 19 — IV 103% · EM ±6.1%Aug 20 — IV 174% · EM ±7.3%Aug 24 — IV 81% · EM ±16.9%Aug 25 — IV 83% · EM ±16.9%Aug 26 — IV 151% · EM ±30.3%Aug 27 — IV 82% · EM ±16.1%Aug 28 — IV 131% · EM ±25.0%Aug 31 — IV 127% · EM ±22.5%Sep 01 — IV 125% · EM ±21.5%Sep 02 — IV 91% · EM ±15.2%Sep 03 — IV 112% · EM ±18.1%Sep 04 — IV 119% · EM ±18.6%Sep 07 — IV 135% · EM ±18.6%Sep 08 — IV 144% · EM ±19.0%Sep 09 — IV 112% · EM ±14.0%Sep 10 — IV 100% · EM ±11.8%Sep 11 — IV 166% · EM ±18.3%Sep 14 — IV 166% · EM ±13.9%Sep 15 — IV 217% · EM ±15.7%Sep 16 — IV 360% · EM ±21.3%Sep 17 — IV 481% · EM ±20.1%Sep 21 — IV 134% · EM ±28.0%Sep 22 — IV 50% · EM ±10.2%Sep 23 — IV 117% · EM ±23.4%Sep 24 — IV 144% · EM ±28.3%Sep 25 — IV 96% · EM ±18.4%Sep 28 — IV 154% · EM ±27.3%Sep 29 — IV 83% · EM ±14.2%Sep 30 — IV 68% · EM ±11.4%Oct 01 — IV 172% · EM ±27.9%Oct 02 — IV 169% · EM ±26.4%

Sector peers

PEPG
PepGen Inc.
$153M $2.52-7.3%
ASRT
Assertio Holdings, Inc.
$151M $23.50
OGI
Organigram Global Inc.
$169M $0.93-1.6%
CNTN
Canton Strategic Holdings, Inc.
$174M $1.86-3.6%
NKTX
Nkarta, Inc.
$183M $1.79+2.3%
CUE
Cue Biopharma, Inc.
$183M $18.66-1.5%

TNXP earnings FAQ

What is TNXP's expected move for earnings?

Options currently price a move of about ±26.4%, or $1.36 per share either way from $5.17.

How does TNXP stock usually react to earnings?

Across the last 2 reports the average next-day move was ±1.0%, up 2 times and down 0 times.

What is TNXP's implied volatility?

TNXP's at-the-money implied volatility is about 169% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in